论文部分内容阅读
目的探讨肿瘤患者自主参与经锁骨下静脉置管知情同意的可行性。方法选取2015年1-6月我院胃癌患者100例,随机分为两组,其中观察组47人,对照组53人。观察组由患者自主参与中心静脉置管前告知并签署知情同意;对照组由患者委托的直系亲属或配偶参与。对两组患者中心静脉置管时及置管后情况进行比较。结果两组患者的置管情况差异无统计学意义(P>0.05);置管后观察组导管相关性感染率相对低于对照组患者,但两者比较差异无统计学意义(P>0.05)。结论患者主动参与中心静脉置管知情同意安全可行,患者可较好配合置管,能相对减少相关并发症的发生,临床可根据实际情况,由患者自主参与知情同意的签署工作。
Objective To investigate the feasibility of tumor patients participating in the informed consent of autonomic subclavian catheterization. Methods 100 patients with gastric cancer in our hospital from January to June in 2015 were randomly divided into two groups, of which 47 were in the observation group and 53 in the control group. Patients in the observation group were informed and signed the informed consent before the patient was autonomously involved in the central venous catheterization. In the control group, the immediate family members or spouses entrusted by the patients were involved. The central venous catheterization and catheterization were compared between the two groups. Results There was no significant difference in catheterization between the two groups (P> 0.05). The catheter-related infection rate in the observation group after catheterization was relatively lower than that in the control group, but there was no significant difference between the two groups (P> 0.05) . Conclusion It is safe and feasible for patients to actively participate in informed consent of central venous catheterization. Patients can be well fitted with catheter and can reduce relative complications. Clinically, patients can participate in the signing of informed consent autonomously according to the actual situation.